About this trial
Observational prospective single-center, non-profit study. Primary objective of the study: To determine if the hypotensive phenotype, defined as one episode of daytime systolic blood pressure (SBP) \<90 mmHg (or two episodes of daytime SBP \<90 mmHg, if mean 24 h SBP is \<125 mmHg) detected at Ambulatory Blood Pressure Monitoring (ABPM) is associated with adverse events at follow up (death, hospitalization, falls, emergency room admission for uncontrolled hypertension, major cardiovascular events)
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥ 75 years
Diagnosis of hypertension according to the criteria of the European Society of Cardiology guidelines [Williams 2018]
Consent of the patient (or legal representative) to participate in the study
Disqualifiers
Refusal of the patient or his/her legal representative
Life expectancy of less than 6 months
Trial population
Elderly hypertensive patients who are enrolled at the Hypertension Centre of Istituto Auxologico italiano IRCCS
Trial design
Cohort
Prospective
Treatments tested in this trial
Diagnostic tests and questionnaires
Diagnostic testAssessment of office blood pressure, orthostatic hypotension, 24-hour ambulatory blood pressure, frailty
Treatment groups
Trial outcomes
Primary outcomes
Incidence of adverse events
Adverse events at follow up (death, hospitalization, falls, emergency room admission for uncontrolled hypertension, major cardiovascular events)
Prevalence of hypotensive phenotype
Hypotensive phenotype, defined as one episode of daytime systolic blood pressure (SBP) \<90 mmHg (or two episodes of daytime SBP \<90 mmHg, if mean 24 h SBP is \<125 mmHg)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.